What Is Gay Chemsex? Health Risks and Harm Reduction

Chemsex refers to the intentional use of specific drugs before or during sex, predominantly among gay, bisexual, and other men who have sex with men. A 2025 systematic review and meta-analysis estimated that roughly one in five men who have sex with men have engaged in chemsex, though prevalence varies widely by region and how the term is defined.¹ The practice sits at an intersection of sexual culture, drug use, mental health, and infectious disease, and understanding it requires looking at each of those dimensions honestly rather than through a lens of moral panic.

What Counts as Chemsex

The term “chemsex” typically refers to a specific cluster of drugs used to enhance or enable sexual encounters. The core substances are methamphetamine (crystal meth), GHB/GBL, and mephedrone. Some researchers use a broader category called “sexualized drug use” that includes cocaine, MDMA, ketamine, alkyl nitrites (poppers), and cannabis when used deliberately in a sexual context. The distinction matters because the narrower definition captures a more specific set of risks, while the broader one captures a larger share of the population.

In a large meta-analysis pooling studies from multiple countries, about 22% of men who have sex with men reported chemsex using the narrower definition, and about 25% reported sexualized drug use using the broader one. Alkyl nitrites were the most commonly used substance at about 23%, followed by cannabis at 18% and GHB/GBL at 13%. Methamphetamine use for sex came in at around 8%, and mephedrone at 7%.² Those numbers reflect a global average; in some cities the rates are considerably higher, while in others the practice barely registers.

A Swiss cohort study found that about 17% of gay and bisexual men used “chems,” with rates higher among those on PrEP (about 21%) than those living with HIV in clinical care (about 11%). Men aged 26 to 37 were the most likely users, and having sex with non-steady partners was by far the strongest predictor, with over twelve times higher odds compared to men who did not have casual partners.³

How the Drugs Work in a Sexual Context

The substances associated with chemsex target the brain in distinct ways that are relevant to why they are chosen specifically for sex rather than recreational partying alone. Methamphetamine and mephedrone flood dopamine and noradrenaline pathways, producing intense euphoria and dramatically increasing sexual arousal, impulsivity, and physical endurance. Sex on stimulants can last for hours or even days, which is part of the appeal but also a significant source of physical harm.⁴

GHB and its precursor GBL work differently. As a GABA receptor agonist, GHB produces relaxation, euphoria, and muscle disinhibition, which users describe as lowering both physical and psychological barriers to sex. The problem is that GHB has an extremely narrow window between the dose that produces a pleasant high and the dose that causes unconsciousness. At higher doses, it can cause profound sedation, hypothermia, coma, and death.⁵ Repeated use also carries a risk of dependence, and withdrawal from GHB can be medically serious.

Ketamine, MDMA, and cocaine play supporting roles in some chemsex settings. MDMA promotes emotional openness and sensory amplification, while ketamine produces dissociative effects that some users find sexually appealing. Polydrug use, taking two or more of these substances during the same session, is common and substantially raises the risk of adverse reactions, because interactions between stimulants and depressants can be unpredictable.

Why People Engage in Chemsex

The motivations are more layered than “wanting to get high and have sex.” Research consistently identifies several overlapping drivers. Chemsex can increase libido, heighten arousal, ease physical discomfort during certain sexual practices, and promote a feeling of confidence and social connection.⁶ For some men, drugs remove inhibitions that make sex difficult without them, whether that difficulty stems from body image, performance anxiety, trauma history, or discomfort with their own sexual desires.

One widely discussed hypothesis is that internalized homophobia drives chemsex: that men use drugs to overcome shame about same-sex attraction. A 2025 meta-analysis of 18 studies involving over 16,000 participants tested this idea directly. The result was a very small and statistically non-significant relationship between internalized sexual prejudice and sexualized drug use. The researchers concluded that the link is complex, inconsistent, and likely shaped by contextual factors that current studies have not captured well.⁷ In other words, the “shame makes men do drugs” narrative is too simple. Some men clearly do describe shame as a factor, but many others engage in chemsex primarily for pleasure, connection, or enhanced physical experience, and the data does not support a blanket causal story.

A qualitative study exploring chemsex and intimacy found that participants described a “quest for intimate connection” and a sense of belonging within a community. At the same time, many were aware that the intimacy they experienced during chemsex sessions was in some sense artificial, a phenomenon researchers described as “false intimacy.” Multiple participants also described complex feelings of shame, though this shame was not always about their sexuality per se; sometimes it was specifically about the chemsex itself and the gap between their behavior during sessions and their values outside them.⁸

Social support appears to matter. A study of 160 men who have sex with men found that lower perceived social support and using drugs by more routes (snorting, swallowing, injecting) predicted more frequent chemsex, while higher social support, stronger sexual desire and arousal, and fewer routes of administration predicted more frequent sober sex.⁹ This pattern suggests that for some men, chemsex fills a gap left by social isolation rather than being a purely recreational choice.

The Role of Apps and Digital Platforms

Geolocation dating apps have changed how chemsex is organized. Research with gay men in Mexico found that specific platforms, particularly mobile geolocation apps, facilitated both access to sexual partners and access to drugs.¹⁰ Drug availability is often signaled through coded language or emojis in user profiles, making it easy for people who want chemsex to find each other and for people who do not to encounter it anyway. This digital ecosystem has shifted chemsex from a subcultural niche into something visible and accessible to a wider range of men, including younger men and those in smaller cities who previously would have had less exposure.

The same platforms also serve as spaces where harm-reduction information circulates informally. Users share dosing guidance, warn each other about dangerous batches, and coordinate agreements about which substances to use. How effective this informal peer education actually is remains unclear, but the fact that digital culture shapes both the risk landscape and the harm-reduction response is significant for anyone designing interventions.

Sexual Health Risks

The link between chemsex and sexually transmitted infections is well established. Drug use during sex is associated with condomless sex, more sexual partners, and group sex, all of which raise infection risk. A Spanish study of over 700 HIV-positive men who have sex with men found that about 29% reported recent sexualized drug use. Those who engaged in it were significantly more likely to report high-risk sexual behaviors and to have been diagnosed with an STI. Hepatitis C was particularly strongly linked to chemsex, with about two and a half times higher odds of diagnosis, and even higher odds for those who injected drugs during sex.¹¹

Hepatitis C deserves special attention because its transmission in this context does not follow the pattern most people expect. While hepatitis C is traditionally associated with injection drug use, in chemsex settings it can spread through shared drug equipment (straws, pipes), through blood-to-blood contact during rough or prolonged sex, and through fisting when gloves are not used. A Taiwanese study found that recreational drug use roughly doubled the odds of hepatitis C viremia among HIV-positive men, and group sex roughly doubled it again.¹²

A prospective cohort study tracking HIV-positive men engaged in chemsex over time found that high-risk sexual behaviors persisted, though syphilis cases actually declined during follow-up. At baseline, 29% had hepatitis C antibodies, and five new acute hepatitis C cases occurred during the study period.¹³ This suggests that chemsex-related STI risk is persistent rather than something that naturally resolves without intervention, but also that targeted programs can reduce some infections even when behavior does not fundamentally change.

Pre-exposure prophylaxis (PrEP) use is substantially more common among men who engage in chemsex than among those who do not. A meta-analysis of 28 studies found that about 39% of men who engaged in chemsex were on PrEP, and that chemsex was associated with more than three times higher odds of PrEP use overall.¹⁴ This is important context: the picture is not purely one of recklessness. Many men in this population are actively managing their HIV risk. However, PrEP does nothing against hepatitis C, syphilis, gonorrhea, or other infections that are also elevated in this context. And PrEP access was significantly lower in studies from low- and middle-income countries, meaning the protective effect is unevenly distributed globally.

Slamming and Its Specific Risks

“Slamming” refers specifically to injecting drugs during sex, most commonly methamphetamine, mephedrone, or a combination. It is a minority practice within chemsex overall but carries disproportionate risk. A French survey of over 2,600 men who have sex with men found that about 3% had ever slammed and about 1.6% had done so in the past year. Both HIV and hepatitis C status were very strongly associated with slamming, with hepatitis C showing over thirteen times higher odds.¹⁵ Poorer mental health was also linked to slamming, with a meaningful increase in odds for each ten-point drop in mental health scores.

Injection adds risks that non-injecting drug use does not carry: vein damage, abscesses, transmission of bloodborne infections through shared needles, and a faster, more intense high that makes overdose more likely. Men who slam often describe it as a distinct escalation from other forms of chemsex, and clinicians who work with this population note that slamming frequently signals deeper dependence and more chaotic patterns of use.

Mental Health and Psychosis

The mental health toll of chemsex extends beyond the immediate effects of intoxication. A systematic review on chemsex and psychosis found that psychotic symptoms occurred in anywhere from about 7% to 37% of chemsex participants across studies, making psychosis one of the most frequently reported psychiatric outcomes. Slamming, polydrug use, and smoking methamphetamine each raised the risk of psychosis up to threefold.¹⁶ Risk factors included being from an ethnic minority, living in a large city, experiencing stress and anxiety, having a trauma history, loneliness, STIs, and previous psychotic episodes.

Methamphetamine-induced psychosis can involve hallucinations, paranoid delusions, and agitation that are clinically indistinguishable from a primary psychotic disorder. These episodes usually resolve after the drug clears the system, but with repeated use they can become more severe and longer-lasting. Some people develop persistent psychotic symptoms even after stopping methamphetamine. Depression and anxiety are also common both during chemsex involvement and after stopping, and the Swiss cohort study noted an association between chemsex drug use and depression in their participants.¹⁷

Consent Under the Influence

One of the most difficult dimensions of chemsex is what happens to sexual consent when participants are heavily intoxicated. GHB’s sedative properties make this particularly acute. A study in Amsterdam found that men who engaged in chemsex reported having “passed out and not remembering what happened” during drug use at dramatically higher rates: about 41% compared to roughly 9% of those who did not engage in chemsex.¹⁸

Qualitative research with people who use GHB in sexual contexts found that while many described positive experiences, several narrated experiences they found distressing and, in some cases, sexually violent.¹⁹ The challenge here is that chemsex cultures often emphasize pushing boundaries and intense experiences, which can make it harder for participants to recognize, name, or report non-consensual encounters. Memory gaps complicate things further: if you cannot remember what happened, you may not know whether your boundaries were crossed.

This is an area where harm-reduction approaches face real tension. A strict abstinence message is unlikely to reach most people engaged in chemsex, but a pure harm-reduction message risks normalizing situations where meaningful consent is impossible. Practitioners working in this space generally try to encourage pre-session agreements about limits, having sober or less-intoxicated people present, and building cultural norms around checking in with partners, but these strategies are imperfect when the drugs themselves impair judgment and consciousness.

Harm Reduction and Treatment

Standard addiction services often fail men engaged in chemsex because the intertwining of sex and drug use creates dynamics that generic substance-use programs are not designed to address. A man whose methamphetamine use is entirely tied to sexual encounters has a different trigger landscape than someone who uses the same drug recreationally at parties, and treatment that ignores the sexual component is unlikely to be effective.

Peer-led programs have shown promise. A systematic review of harm-reduction interventions for chemsex found that web-based tools improved self-efficacy to refuse risky behaviors and accept HIV testing, and that peer-led programs were especially effective when facilitators had personal experience with chemsex dependence.²⁰ The M3THOD study, a peer-led intervention targeting crystal methamphetamine and GHB use, found that the approach was acceptable and feasible. Participants reported that peers’ personal experiences of chemsex built rapid rapport and helped reduce the shame that often prevents men from seeking help. The evaluation emphasized that peer workers themselves need substantial support to do this work safely.²¹

For methamphetamine specifically, contingency management, a behavioral approach where people earn incentives for drug-free urine samples, has the strongest evidence base. A systematic review found that 20 out of 21 studies reporting abstinence outcomes showed a positive effect, and 7 of 9 studies that measured sexual risk behavior found that contingency management reduced it.²² A community-based program using this approach with methamphetamine-using men who have sex with men achieved a median of over seven weeks of confirmed abstinence per participant.²³ There is no equivalent medication for methamphetamine addiction comparable to what exists for opioid or alcohol use disorders, which makes behavioral interventions like contingency management especially important.

Barriers to Seeking Help

Many men who want to change their chemsex behavior face a confusing service landscape. Sexual health clinics, mental health services, and drug and alcohol programs each address one piece of the puzzle, but rarely all three together. A Taiwanese study of 152 men who reported chemsex found that while about 69% expressed an intention to reduce, actual service use was low: only about 23% had attended a chemsex recovery group, 17% had visited a mental health clinic, and about 11% had used both. Having the intention to reduce was strongly associated with visiting a mental health clinic, suggesting that motivation alone is not the bottleneck; access and integration are.²⁴

Stigma compounds the access problem. Men may fear judgment from healthcare providers who are unfamiliar with chemsex culture or who conflate all drug use with recklessness. In countries where same-sex activity or drug possession carries criminal penalties, the barriers are even steeper. The M3THOD evaluation specifically noted that mainstream services often left participants’ needs around chemsex unmet, reinforcing the case for specialized or integrated programs that address sexuality, substance use, and mental health together rather than in separate silos.

GHB Overdose and the Dosing Problem

GHB deserves a standalone mention because its overdose profile is unlike the other chemsex drugs and is the most common acute emergency in chemsex settings. The gap between a recreational dose and a dangerous one is small, and it varies depending on body weight, tolerance, whether the person has eaten, and whether other depressants like alcohol are in their system. A person who takes GHB safely one night can overdose on the same amount the next night because they had a drink beforehand. The result is profound sedation that can tip into coma or respiratory arrest.²⁵ Repeated GHB use also creates dependence more quickly than many users expect, and the withdrawal syndrome, which can include seizures and delirium, is medically dangerous and requires supervised management. Harm-reduction guidance emphasizes using a measured syringe rather than eyeballing doses, setting a timer between doses, never mixing GHB with alcohol, and having someone present who is sober enough to call emergency services if needed.

Chemsex in Low- and Middle-Income Countries

Most chemsex research has been conducted in Western Europe, Australia, and North America, but the practice is not limited to high-income settings. A survey of gay and bisexual men in Nepal found that about 25% had ever engaged in chemsex, with about 19% involved in the past year. Having multiple sexual partners, participating in group sex, and experiencing depressive symptoms were all associated with recent chemsex.²⁶ ²⁷

The drugs used may differ by region. Methamphetamine dominates in parts of East and Southeast Asia and the Americas, while mephedrone and GHB are more common in Western European chemsex scenes. Local drug markets, price, and availability shape what ends up being used, which in turn shapes the risk profile. PrEP access is also unevenly distributed: the meta-analysis on PrEP and chemsex found that men in low- and middle-income countries had roughly half the odds of being on PrEP compared to those in wealthier settings.²⁸ This gap means that the same behavior carries higher HIV risk in settings with fewer biomedical tools available to reduce it. Criminalization of both drug use and homosexuality in many of these countries further restricts access to health services and research participation, meaning the true prevalence and impact are probably underestimated.